Among the top pulmonology & lung surgery hospitals in New York and the country.
Our program is led by renowned physicians and a comprehensive multidisciplinary team. With expert leadership, a strong research component, and unsurpassed patient survival rates, our lung transplantation program has been top-ranked in the Nation for the past 10 years.
Can a Common Antibiotic Slow Progression of Emphysema in Persons with HIV?
Weill Cornell Medicine pulmonologist and infectious disease specialist collaborate on an NIH-funded phase 2 clinical trial to test if doxycycline will slow progression of emphysema in people with HIV.
ECMO and Early Mobilization: When is it Feasible and Safe?
A Columbia medical intensivist and specialist in extracorporeal membrane oxygenation presents factors associated with intensity of treatment for patients in cardiopulmonary failure.
Idiopathic Pulmonary Fibrosis: Rare Variants Link a New Gene and Pathway to Disease
Columbia physician-scientists in pulmonology uncover a new gene and a new pathway responsible for the development of IPF.
Pragmatic Trial Design Provides New Structure for Studies in IPF
Weill Cornell Medicine pulmonologist and lead investigator reflects on the completion of the CleanUP-IPF clinical trial as a valid design for studying idiopathic pulmonary fibrosis.
COVID-19: Investigating the Persistence of Severe Respiratory Symptoms
Columbia pulmonary and critical care medicine faculty partner with radiologists to study enduring pulmonary consequences in patients following hospitalization for SARS-CoV-2.
An Expert Makes the Case for Pneumococcal Vaccinations
Weill Cornell Medicine pulmonologist leads a comprehensive review of effectiveness and efficacy of the 23-valent polysaccharide vaccine.
Novel Technique Provides Insights into Lung Pathology in COVID-19
Investigators at Weill Cornell Medicine and NewYork-Presbyterian used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.
COVID-19: One Year Later
Pulmonologists and critical care medicine specialists at NewYork-Presbyterian Hospital, Columbia University, and Weill Cornell Medicine continue to share their observations and present their research findings on severe acute respiratory syndrome coronavirus 2.
Lung Transplantation: Decades of Experience and Expertise
Since the inception of the new program nearly two decades ago, the Lung Transplantation Program at NewYork-Presbyterian/
Sleep and Cardiovascular Risk: A Causal Relationship?
Sleep is increasingly recognized as an important contributor to health, yet many Americans regularly do not get enough sleep. To learn if inadequate sleep increases their risks of heart disease, NYP Columbia study the relationship between sleep habits and cardiovascular risk factors.
IPF: Looking to the Microbiome for New Treatments
Despite years of investigations, the origin of idiopathic pulmonary fibrosis has remained elusive. Researchers at NewYork-Presbyterian/Weill Cornell are looking into new therapies to slow the progression.
Newsletters for Medical Professionals
2022 Issue 1
2021 Issue 2
- Investigating the Genetic Connections to Inherited Lung Disease
- Multipronged Management of Interstitial Lung Disease
2021 Issue 1
- Dr. Christine Garcia Named Chief of Pulmonary, Allergy, and Critical Care at Columbia
- The Road Back: Helping Patients Recover Post-ICU
- IPF: Looking to the Microbiome for New Treatments
- Sleep and Cardiovascular Risk: A Causal Relationship?
- Promoting Global Lung Health
- East African Training Initiative at Work in Ethiopia
- Dr. Fernando J. Martinez Leads Pulmonary and Critical Care Medicine at Weill Cornell